B
BDSX
BIODESIX INC
20.34
-1.51-6.91%After Hours: 20.68 +0.34 +1.67%16:15 07/07 EDT
OPEN/PREV CLOSE21.79/21.85
TODAY RANGE19.89-22.33
VOL89.99K
MARKET CAP210.64M
52 WEEK RANGE5.26-24.92
AVG VOL (3M)74.14K
% TURNOVER0.87%
TURNOVER--
P/E (TTM)-5.0518
% RANGE11.16%
EPS(TTM)-4.0263
P/E(FORWARD)-6.8485
P/B22.51
BVPS0.9035
DIVIDEND--
P/S1.897
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP112.59M
SHARES OUTSTANDING10.36M
NEXT EARNINGS08/05-08/10
FREE FLOAT5.54M
LOT SIZE1
EX-DATE09/15/2025
News
Press Releases
Financial Reports
Profile
NASDAQ·06/29 08:18
5 Biotech Stocks That Skyrocketed 105% To 235% — TWST, INDV, MIRM & More
Dow Jones·06/25 11:08
Biodesix Initiated at Buy by Roth Capital
TipRanks·06/24 22:25
Roth starts Biodesix at Buy, says positioned to deliver durable growth
NASDAQ·06/19 14:23
Baxter's Unit Synovis MCA to Lead Global Rollout of the SHIYA Platform
NASDAQ·06/19 08:27
Biodesix (BDSX) Surges 10.5%: Is This an Indication of Further Gains?
Dow Jones·06/18 13:26
Biodesix Price Target Raised to $27.00/Share From $22.00 by Canaccord Genuity
Dow Jones·06/18 13:26
Biodesix Is Maintained at Buy by Canaccord Genuity
Benzinga·06/18 13:17
Canaccord Genuity Maintains Buy on Biodesix, Raises Price Target to $27
TipRanks·06/18 10:55
Biodesix price target raised to $27 from $22 at Canaccord
Reuters·06/18 07:14
U.S. RESEARCH ROUNDUP- Datadog, Jabil, Prologis
Reuters·06/18 05:58
BIODESIX INC <BDSX.O>: CANACCORD GENUITY RAISES TARGET PRICE TO $27 FROM $22
Benzinga·06/15 13:15
This ICU Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Dow Jones·06/15 10:27
Biodesix Initiated at Buy by HC Wainwright & Co.
Dow Jones·06/15 10:27
Biodesix Price Target Announced at $26.00/Share by HC Wainwright & Co.
Same Industry
Name/Symbol
Change%
Price